RecruitingNCT06838611

ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation


Sponsor

Medical University of Warsaw

Enrollment

300 participants

Start Date

Nov 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to characterize the population of patients qualified for transcatheter tricuspid valve interventions (TTVI). It is expected to: * Describe the profile of patients qualified for TTVI * Establish the most common causes for disqualification from TTVI * Evaluate the immediate and long-term efficacy of TTVI * Evaluate TTVI safety Participants will undergo a standard qualification procedure for TTVI and then will be subject to a follow-up consisting of clinical examination, echocardiography and laboratory testing.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • tricuspid regurgitation
  • qualification for transcatheter tricuspid valve intervention

Exclusion Criteria4

  • tricuspid regurgitation qualified for surgical treatment
  • concomitant left heart valve disease qualified for surgical treatment
  • multivessel coronary artery disease qualified for coronary artery bypass grafting
  • lack of patient's consent to enter the registry

Interventions

DEVICETranscatheter edge-to-edge repair

Transcatheter edge-to-edge repair of the tricuspid valve for the treatment of severe tricuspid valve regurgitation.


Locations(1)

First Department of Cardiology, Medical University of Warsaw

Warsaw, Masovian Voivodeship, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06838611


Related Trials